Sinopharm Group Co (HKSE:01099) Inventories, Raw Materials & Components: HK$219 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:01099 Sinopharm Group Co Ltd HKSE:01099
86 GF Score
Price HK$17.62
GF Value HK$20.95
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Sinopharm Group Co Inventories, Raw Materials & Components?

Sinopharm Group Co HKSE:01099 +0.28% 86 Inventories, Raw Materials & Components is HK$219 Mil as of Dec. 2025. GuruFocus rates HKSE:01099 with a GF Score™ of 86/100 and a GF Value™ of HK$20.95 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Sinopharm Group Co's inventories, raw materials & components for the quarter that ended in Dec. 2025 was HK$219 Mil.

Sinopharm Group Co's quarterly raw materials declined from Dec. 2024 (HK$227 Mil) to Jun. 2025 (HK$0 Mil) but then increased from Jun. 2025 (HK$0 Mil) to Dec. 2025 (HK$219 Mil).

Sinopharm Group Co's annual raw materials declined from Dec. 2023 (HK$251 Mil) to Dec. 2024 (HK$227 Mil) and declined from Dec. 2024 (HK$227 Mil) to Dec. 2025 (HK$219 Mil).

Sinopharm Group Co Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for Sinopharm Group Co's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sinopharm Group Co Inventories, Raw Materials & Components Chart

Sinopharm Group Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 227.14 300.84 251.19 227.29 218.88

Sinopharm Group Co Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 251.19 0.00 227.29 0.00 218.88
HKSE:01099
86GF Score
Sinopharm Group Co Ltd HKSE:01099
Inventories, Raw Materials & Components is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sinopharm Group Co Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of HK$219 Mil mean?
Sinopharm Group Co (HKSE:01099) has a Inventories, Raw Materials & Components of HK$219 Mil as of Dec. 2025. Raw materials are the components a company uses for its main products. View historical data on Sinopharm Group Co and its competitors.
Is Sinopharm Group Co's Inventories, Raw Materials & Components too high?
Sinopharm Group Co's current Inventories, Raw Materials & Components is HK$219 Mil. Overall, Sinopharm Group Co has a GF Score™ of 86/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sinopharm Group Co's Inventories, Raw Materials & Components compare to MCK and CAH?
Sinopharm Group Co's Inventories, Raw Materials & Components of HK$219 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Medical Distribution company?
A good Inventories, Raw Materials & Components depends on the Medical Distribution industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Sinopharm Group Co and its competitors. Sinopharm Group Co's current Inventories, Raw Materials & Components is HK$219 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sinopharm Group Co stock overvalued right now?
Based on GuruFocus' analysis, Sinopharm Group Co (HKSE:01099) is currently considered Modestly Undervalued. The stock's GF Value™ is HK$20.95, compared to a current price of HK$17.62 — trading 15.9% below its estimated fair value. The current Inventories, Raw Materials & Components is HK$219 Mil. Sinopharm Group Co's overall GF Score™ is 86/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Sinopharm Group Co (HKSE:01099), the current Inventories, Raw Materials & Components is HK$219 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sinopharm Group Co (HKSE:01099) Overvalued in 2026?

Based on GuruFocus' analysis, Sinopharm Group Co stock appears to be undervalued. The current stock price of HK$17.62 is trading 15.9% below its estimated GF Value™ of HK$20.95. GuruFocus considers Sinopharm Group Co to be Modestly Undervalued.

Key valuation signals for HKSE:01099:

  • Inventories, Raw Materials & Components: HK$219 Mil
  • GF Value™: HK$20.95 vs. price of HK$17.62 (15.9% below fair value)
  • GF Score™: 86/100 with 4 warning signs

No single metric tells the full story. See the HKSE:01099 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sinopharm Group Co Business Description

Address No. 385, East Longhua Road, Sinopharm Group Building, Huangpu District, Shanghai, CHN, 200023
Founded in 2003, Sinopharm is the largest wholesaler and retailer of drugs and medical devices in China and listed on the Hong Kong Stock Exchange in 2009. It is a core subsidiary of China National Pharmaceutical Group. Sinopharm's largest operating segment is pharmaceutical distribution, making up over 70% of its total revenue by the end of 2024. In 2018, Sinopharm acquired the largest Chinese medical device distributor, China National Scientific Instruments and Materials. Now, medical device distribution accounts for over 20% of Sinopharm's total revenue. Sinopharm's downstream customers range from hospitals and other health services institutions to end-customers.
86GF Score

Get the complete analysis for HKSE:01099

Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$17.62
Price
HK$20.95
GF Value